Navigation Links
Mayo Clinic Proceedings: November highlights
Date:11/2/2010

The November issue of Mayo Clinic Proceedings includes three articles with leading research, highlighted below.

Khat Chewing Increases Risk of Stroke and Death in Patients With Acute Coronary Syndrome

ROCHESTER, Minn. -- Researchers found that people who chew khat and present with acute coronary syndrome had significantly higher rates of death, cardiogenic stroke, and stroke complications, despite having lower cardiovascular risk profiles.

"The leaves of khat, a leafy green shrub, are chewed habitually for euphoric and stimulating effects. The main ingredients, cathinone and cathine, are structurally related to amphetamine and ecstasy," says lead author Waleed Ali, M.D., from Hamad General Hospital in Doha, Qatar. An estimated 5 million to 10 million people worldwide chew khat, predominantly those living in the horn of Africa and the Arabian Peninsula, according to an editorial written by Farrah Mateen, from Johns Hopkins University in Baltimore, and Gregory Cascino, M.D., from the Department of Neurology at Mayo Clinic. They further state that Khat is illegal in the United States, and is not currently an accepted form of medical treatment.

Dr. Ali says, "Patients of Eastern African and Yemeni origins should be evaluated and counseled about khat chewing, even when living in Western countries."


Are Energy Beverages Safe to Drink When Exercising?

ROCHESTER, Minn. -- The resurgence of exercise has been accompanied by multiple supplements, sports drinks, and energy beverages that promise to enhance performance, muscle growth, and recovery. But the question remains: Are energy beverages safe?

"One can of an energy beverage during one session of exercise is safe for most healthy individuals," says John Higgins, M.D., lead author from The University of Texas Medical School in Houston. However, he states, "excess consumption and consumption with other caffeine-containing beverages or alcohol may lead to adverse effects and possibly death."

The United States is the world's largest consumer of energy beverages by volume, and consumption is primarily among people ages 11 to 35 years. The most common ingredient is caffeine, which ranges from 50 milligrams (mg) to 505 mg per 16-ounce serving.


Perspectives on Withdrawing Pacemakers and Implantable Cardioverter-Defibrillators at End of Life Vary Substantially

ROCHESTER, Minn. -- Mayo Clinic researchers found that the majority of medical professionals and patients feel implantable cardiac device (ICD) therapy should be withdrawn based on the patient's right to refuse continued life-sustaining therapy at the end of life.

"Almost one-third of medical professionals surveyed considered withdrawal of a pacemaker in a pacemaker-dependent patient as physician-assisted suicide or euthanasia, but only a very small percentage believed the same about an ICD," says Samuel Asirvatham, M.D., lead author and cardiologist, Mayo Clinic. The article noted that legal professionals tend to view all devices as similar and saw little difference between withdrawal of an ICD and withdrawal of a pacemaker.

"Education and discussion of managing devices at the end of life are important when making end-of-life decisions to better understand patients' perceptions and expectations," says Dr. Asirvatham.


'/>"/>

Contact: Rebecca Eisenman
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. The West Clinic Joins Cancer Clinics of Excellence (CCE)
2. Stethoscope App gives iPhone New Clinical Skills
3. Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota
4. Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US
5. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
6. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
7. Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
10. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
11. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... NY (PRWEB) , ... May 27, 2016 , ... This ... of a stroke, which we as a society can control and change. , As ... occurs nearly every 40 seconds within the United States. Plus, with an estimated 129,000 ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Beleza Medspa ... body fat composition regulations. This is the first time that Coolsculpting is being ... at least every six months to ensure they meet the prescribed body-fat standard, measured ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year ... medicine. Allison Outerbridge is this year’s Life University winner of a ... the university’s Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... outcomes, hosted members and suppliers for its inaugural Member Conference at the Paris ... mission of elevating the operational health of America’s healthcare providers. , The conference ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May 25, 2016 ... ; Frankfurt Prime Standard: QIA) today announced that the company ... Diagnostics GmbH to develop and commercialize predictive assays in oncology. ... as a marker to predict effectiveness of anthracycline treatment in ... "We are pleased to partner with Therawis, which developed the ...
(Date:5/25/2016)... Florida , May 25, 2016 ... Conference & Expo earlier this month, the numbers and ... revenues continue to climb into the billions, more research ... newly released 4th Edition State of Legal Marijuana Markets ... a cannabis-focused data-analysis firm, much of the increase in ...
Breaking Medicine Technology: